iCoreConnect Inc. Stock Price, News & Analysis

iCoreConnect (OTCQB: ICCT) reported robust financial results for Q3 and the nine months ending September 30, 2022. Revenue surged 38% to $1.9 million for the quarter and 95% to $5.9 million year-to-date, driven by strong SaaS adoption. Gross profit rose 45% to $1.4 million, with gross margins improving to 72.6%. The company achieved approximately 30,000 subscriptions, a significant increase compared to 18,000 the previous year. Notable business expansions include partnerships with key dental associations and integration with Carestream Dental to enhance service offerings across the U.S.

iCoreConnect (OTCQB: ICCT) received endorsement from the New York State Dental Association (NYSDA) for its iCoreVerify software, aimed at enhancing the insurance verification process for dental practices. This marks NYSDA's second endorsement of iCoreConnect, highlighting a long-standing trust since their first endorsement of iCoreExchange over five years ago. With nearly 13,000 members, NYSDA's support signifies a strong validation for iCoreConnect's cloud-based solutions, which integrate seamlessly with existing practice management systems, freeing staff for essential patient care tasks.

iCoreConnect has announced a significant partnership with Carestream Dental, integrating its cloud-based software with Carestream's practice management solutions. This integration will enhance operational efficiencies for over 15,000 dental practices by improving healthcare workflows and productivity. CEO Robert McDermott emphasized the partnership's potential to increase sales and boost practice management effectiveness. iCoreConnect is recognized for its 15 SaaS solutions and nearly 90 agreements with healthcare associations across the U.S.

iCoreConnect, Inc. (OTCQB: ICCT) announced a new integration partnership with toothapps, enhancing its Connected Dentistry™ platform. This collaboration will facilitate interoperability, providing dental practices with improved access to oral wellness solutions. iCoreConnect’s offerings like ePrescribing and automated insurance verification will streamline administrative tasks, leading to increased efficiency. This partnership aims to bridge gaps in electronic health data exchange, expanding opportunities in both dental and medical fields.

iCoreConnect, Inc. (OTCQB: ICCT) has launched iCoreHIPAA, a HIPAA-compliant risk assessment software aimed at healthcare providers. This new product addresses customer needs for conducting Security Risk Analysis, HIPAA Training, and tracking Business Associate Agreements. iCoreHIPAA automates risk assessments while providing templates and guidance for complying with HIPAA’s security rule. With nearly 90 endorsements from medical and dental associations and 30,000 subscribers, iCoreConnect is enhancing its market presence while maintaining a low attrition rate of under 1%.

iCoreConnect (OTCQB: ICCT) announced strong Q2 2022 results, reporting $2.1MM in revenue, a 210% increase compared to Q2 2021. Notable metrics include Annual Recurring Revenue rising to $1.8MM (200% growth) and total revenues of $2.0MM (285% growth). The company added 15,000 new subscribers, bringing total recurring subscribers to approximately 27,000, up 225% from the previous year. iCoreConnect's growth is driven by its electronic prescription service, iCoreRx, and the launch of iCoreVerify.

iCoreConnect (OTCQB: ICCT) has relocated its corporate headquarters to a larger facility in Ocoee, Florida, driven by growth in its sales, implementation, and support teams. The company, known for its SaaS solutions that enhance productivity in the dental and medical sectors, aims to optimize workflow and customer profitability through its extensive platform of applications. The new headquarters is expected to support its expanding operations and commitment to addressing healthcare business challenges.

iCoreConnect (OTCQB: ICCT) announced the purchase of 900,145 common shares by members of its executive team, equating to about 0.5% of outstanding shares. Robert McDermott, the President and CEO, highlighted the company’s consistent growth and expressed confidence in its software solutions aimed at the healthcare sector. iCoreConnect focuses on enhancing business productivity and profitability within the dental and medical industries, boasting a robust platform of 15 SaaS enterprise solutions and nearly 80 partnerships with healthcare associations nationwide.

iCoreConnect (OTCQB: ICCT) reported strong financial results for Q1 2022, achieving $2 million in revenue, a 285% increase from Q1 2021. Annual Recurring Revenue (ARR) also surged by 317% to $1.9 million, with a notable increase of 14,000 subscribers bringing the total to approximately 25,000. The company reduced its quarterly loss to $285,000, down from $392,000, due to improved margins and lower expenses as a percentage of revenue. iCoreConnect continues to expand its cloud-based software solutions to enhance workflow productivity.